Coronaviruses can cause viral pneumonia with extrapulmonary manifestations and complications. Many patients have either underlying cardiovascular disease or cardiac risk factors. Acute heart attacks are also frequent in severe cases of coronavirus disease 2019 (COVID-19), which is associated with high mortality. In this paper, we describe a patient with COVID-19 who presented with myocardial infarction (MI) symptoms but lacked the initial symptoms of the infection such as fever and cough. COVID-19 and myocardial infarction were diagnosed. The patient underwent thrombolytic treatment and fully recovered.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551257 | PMC |
| http://dx.doi.org/10.18502/jthc.v17i1.9323 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Uncommon etiology of ST-elevation myocardial infarction: Behçet's disease-induced coronary aneurysm.
J Invasive Cardiol
December 2024
University of Texas, MD Anderson Cancer Center, Houston, Texas. Email:
Artificial Intelligence-Enhanced Electrocardiography for Prediction of Incident Hypertension.
JAMA Cardiol
January 2025
National Heart and Lung Institute, Imperial College London, United Kingdom.
Importance: Hypertension underpins significant global morbidity and mortality. Early lifestyle intervention and treatment are effective in reducing adverse outcomes. Artificial intelligence-enhanced electrocardiography (AI-ECG) has been shown to identify a broad spectrum of subclinical disease and may be useful for predicting incident hypertension.
View Article and Find Full Text PDFIL-1 blockade in myocardial infarction and its efficacy in patients with complex coronary artery disease. Another brick in the wall.
J Cardiovasc Pharmacol
January 2025
School of Cardiovascular and Metabolic Medicine & Sciences, King's College London British Heart Foundation Centre of Excellence, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Anatomic vs. Ischemia-Driven Strategies for Percutaneous Coronary Revascularization in Chronic Coronary Syndrome: A Network Meta-Analysis.
Catheter Cardiovasc Interv
January 2025
Division of Cardiology, Department of Medical Science, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Introduction: In patients with chronic coronary syndromes (CCS), the benefit of percutaneous coronary intervention (PCI) added to optimal medical therapy (OMT) remains unclear. The indication to PCI may be driven either by angiographic evaluation or ischemia assessment, thus depicting different potential strategies which have not yet been thoroughly compared.
Methods: Randomized controlled trials (RCTs) comparing OMT versus PCI angio-guided or versus PCI non-invasive or invasive ischemia guided were identified and compared via network meta-analysis.
Acute myocardial infarction (MI) is a leading cause of death worldwide. Although with current treatment, acute mortality from MI is low, the damage and remodeling associated with MI are responsible for subsequent heart failure. Reducing cell death associated with acute MI would decrease the mortality associated with heart failure.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!